OXY
42
17
KSS
36
2
BDX
59
3
VNO
46
6
HIG
48
5
URBN
67
3
CME
59
3
MTB
38
4
COP
36
2
INTC
35
4
DRI
74
5
BEN
36
4
PFG
27
7
ADT
12
2
NVDA
52
5
AKAM
50
2
PSA
43
6
TAP
57
6
RCL
74
5
XEL
48
11
OXY
42
17
KSS
36
2
BDX
59
3
VNO
46
6
HIG
48
5
URBN
67
3
CME
59
3
MTB
38
4
COP
36
2
INTC
35
4
DRI
74
5
BEN
36
4
PFG
27
7
ADT
12
2
NVDA
52
5
AKAM
50
2
PSA
43
6
TAP
57
6
RCL
74
5
XEL
48
11
Financhill
Back

Artiva Biotherapeutics 10K Form

Sell
31

ARTV
Artiva Biotherapeutics

Last Price:
$10.45
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ARTV News And Ratings

See the #1 stock for the next 7 days that we like better than ARTV

ARTV Financial Statistics

Sales & Book Value

Annual Sales: $33.5M
Cash Flow: $-15.1M
Price / Cash Flow: 0
Annual Sales: $-9.93
Price / Book: 0

Profitability

EPS (TTM): -3.08220
Net Income (TTM): $-54.2M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -38.54%

Artiva Biotherapeutics Earnings Forecast

Key Artiva Biotherapeutics Financial Ratios

  • The Research & Development expenses have been 150.04% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ARTV is -82.69% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Artiva Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ARTV
Website: artivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.35
Quick Ratio: 6.16

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ARTV Technical Analysis vs Fundamental Analysis

Sell
31
Artiva Biotherapeutics (ARTV) is a Sell

Is Artiva Biotherapeutics a Buy or a Sell?